Renaissance Technologies - GAIN THERAPEUTICS INC ownership

GAIN THERAPEUTICS INC's ticker is GANX and the CUSIP is 36269B105. A total of 25 filers reported holding GAIN THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 4.67 and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of GAIN THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$151,936
+86227.3%
118,700
+154.2%
0.00%
Q1 2024$176
+25.7%
46,700
+9.1%
0.00%
Q4 2023$140
-9.1%
42,800
-8.7%
0.00%
Q3 2023$154
-27.7%
46,900
-1.5%
0.00%
Q2 2023$213
+13.9%
47,600
+23.0%
0.00%
Q1 2023$187
+79.8%
38,700
+16.6%
0.00%
Q4 2022$104
-99.9%
33,200
-0.6%
0.00%
Q3 2022$109,000
-8.4%
33,400
+0.9%
0.00%
Q2 2022$119,00033,1000.00%
Other shareholders
GAIN THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Timelo Investment Management Inc. 605,288$774,7690.44%
Cable Car Capital LLC 145,000$185,6000.20%
CM Management, LLC 90,000$115,2000.11%
HOHIMER WEALTH MANAGEMENT, LLC 330,000$422,4000.10%
DME Capital Management, LP 566,130$724,6460.04%
Warberg Asset Management LLC 51,600$65,5320.01%
PRELUDE CAPITAL MANAGEMENT, LLC 35,820$45,8500.00%
Alyeska Investment Group, L.P. 450,000$576,0000.00%
Gilbert & Cook, Inc. 10,000$12,8000.00%
Virtu Financial LLC 27,356$350.00%
View complete list of GAIN THERAPEUTICS INC shareholders